Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is highly rated in 4 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is highly rated in 9 conditions, according to our data. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is highly rated in 5 conditions, according to our data. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin. Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center. He earned his M.D. from the Columbia University College of Physicians and Surgeons. His research interests include tick-borne diseases and point of care information technology. Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America. Dr. Auwaerter is highly rated in 2 conditions, according to our data. His top areas of expertise are Lyme Disease, Infectious Myocarditis, Babesiosis, and Osteomyelitis.

Dr. Christopher Hoffmann's primary appointment is in the Department of Medicine, Division of Infectious Diseases. His areas of clinical expertise include HIV/AIDS and infectious diseases. Dr. Hoffmann earned his M.D. and M.P.H. from Oregon Health and Sciences University. He completed his residency at Johns Hopkins and performed a fellowship in infectious diseases at Johns Hopkins. His research interests include care delivery and care utilization, in low- and middle-income settings (mostly Africa), and clinical management of HIV and TB. Dr. Hoffmann is a member of several professional organizations, including the American College of Physicians and the Infectious Diseases Society of America. Dr. Hoffmann is highly rated in 1 condition, according to our data. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Ulrike Kirsten Buchwald is an infectious diseases and HIV physician who attended Medical School in Germany and completed training in internal medicine residency and infectious diseases at New York University. In 2010, she joined the University of Maryland School of Medicine, Division of Infectious Diseases and the Institute of Human Virology. Dr. Buchwald received training in anal cancer screening and high-resolution anoscopy (HRA) and started a dedicated anal cancer screening clinic known as the Anal Lesion Evaluation Research Treatment (ALERT) clinic at the University of Maryland. She was the director of the ALERT clinic and in 2017 co-founded the Maryland Consortium for Anal Cancer Screening (MCACS) with Dr. Joyce Jones, Johns Hopkins Department of Medicine, and colleagues from the Department of Colorectal Surgery, to strengthen clinical care and research for HPV-related anal disease. She joined the Division of Gastroenterology and Hepatology at Johns Hopkins in 2019 to build a multi-disciplinary team dedicated to anal cancer screening, and to increase access to high-resolution anoscopy services and HPV-related anal dysplasia treatment for high-risk patients in Baltimore and the region. Recent News Articles and Media Coverage Making Anal Cancer Screening a Priority for High-Risk Patients Hopkins Medicine. Dr. Buchwald is highly rated in 2 conditions, according to our data. Her top areas of expertise are Strep Throat, Chronic Graft Versus Host Disease (cGvHD), Pneumonia, and Meningitis.

Dr. Christopher K. Lippincott is an infectious diseases specialist at the Johns Hopkins University School of Medicine. He is the Clinical Director for the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis. He is an expert in the care of patients with mycobacterial infections (NTM and tuberculosis), HIV/AIDS, Lyme disease, and general infectious diseases. He provides teaching to medical students, residents and fellows at the Johns Hopkins University School of Medicine. Dr. Lippincott earned his M.D. at the University of Virginia School of Medicine. He completed his residency at The Ohio State University Wexner Medical Center and infectious diseases fellowship at the University of North Carolina Hospitals. He also earned a Master of Public Health in epidemiology from the University of North Carolina at Chapel Hill in 2013. Prior to joining Johns Hopkins University in 2015, Dr. Lippincott practiced infectious diseases internationally for Medecins Sans Frontieres (Abkhazia, Georgia) and Right to Care (Johannesburg, South Africa). Dr. Lippincott’s research interests include mycobacterial infections (NTM and tuberculosis) and bronchiectasis. Dr. Lippincott is highly rated in 2 conditions, according to our data. His top areas of expertise are Swimming Pool Granuloma, Nontuberculous Mycobacterial Lung Disease, Osteomyelitis, and Osteomyelitis in Children.

Dr. Maryana Shenderov is a clinician at the Johns Hopkins University School of Medicine, having joined in 2016. Her area of clinical expertise is infectious disease. She earned her M.D. from SUNY Downstate Medical Center. She completed her residency and a fellowship in infectious diseases at the University of Maryland Medical Center. Dr. Maryana Shenderov sees patients at the Greenspring Station and Bartlett Infectious Diseases Clinics and also provides inpatient consultations at Johns Hopkins Hospital. She is committed to excellence in patient care, multi-disciplinary collaboration, and patient-centered care. Dr. Shenderov is highly rated in 2 conditions, according to our data. Her top areas of expertise are Osteomyelitis, Osteomyelitis in Children, SAPHO Syndrome, and Chronic Recurrent Multifocal Osteomyelitis.

Dilraj Deol is an Infectious Disease provider in Baltimore, Maryland. Dr. Deol is highly rated in 12 conditions, according to our data. Her top areas of expertise are Cellulitis, Infective Endocarditis, Myelitis, and AIDS Dementia Complex. Dr. Deol is currently accepting new patients.

Paul Eder is an Infectious Disease provider in Baltimore, Maryland. Dr. Eder is highly rated in 7 conditions, according to our data. His top areas of expertise are Infectious Arthritis, Osteomyelitis, Osteomyelitis in Children, and Myelitis. Dr. Eder is currently accepting new patients.

Theodore Bailey is an Infectious Disease provider in Baltimore, Maryland. Dr. Bailey is highly rated in 6 conditions, according to our data. His top areas of expertise are Sepsis, Osteomyelitis, SAPHO Syndrome, and Osteomyelitis in Children. Dr. Bailey is currently accepting new patients.

Sarah Schmalzle is an Infectious Disease provider in Baltimore, Maryland. Dr. Schmalzle has been practicing medicine for over 17 years is highly rated in 6 conditions, according to our data. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, AIDS Dementia Complex, and Splenectomy. Dr. Schmalzle is currently accepting new patients.

David Riedel is an Infectious Disease provider in Towson, Maryland. Dr. Riedel is highly rated in 5 conditions, according to our data. His top areas of expertise are HIV/AIDS, Febrile Neutropenia, Myelitis, and AIDS Dementia Complex. Dr. Riedel is currently accepting new patients.

Kjell Wiberg is an Infectious Disease provider in Baltimore, Maryland. Dr. Wiberg is highly rated in 5 conditions, according to our data. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Wiberg is currently accepting new patients.

Chandralekha Banerjee is an Infectious Disease provider in Baltimore, Maryland. Dr. Banerjee is highly rated in 5 conditions, according to our data. Her top areas of expertise are Myelitis, AIDS Dysmorphic Syndrome, HIV/AIDS, and AIDS Dementia Complex. Dr. Banerjee is currently accepting new patients.

John Beigel is an Infectious Disease specialist and an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Beigel is highly rated in 5 conditions, according to our data. His top areas of expertise are Flu, Severe Acute Respiratory Syndrome (SARS), Togaviridae Disease, and Zika Virus Disease.

John Cmar is an Infectious Disease provider in Baltimore, Maryland. Dr. Cmar is highly rated in 4 conditions, according to our data. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Heather Nace is an Infectious Disease provider in Towson, Maryland. Dr. Nace is highly rated in 3 conditions, according to our data. Her top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Infective Endocarditis, and Endocarditis. Dr. Nace is currently accepting new patients.

Dr. Andrea L. Cox is a professor of Internal Medicine at the Johns Hopkins University School of Medicine in the Division of Infectious Diseases and is a member of the Johns Hopkins Kimmel Cancer Center. She holds joint appointments in Oncology and at the Johns Hopkins Bloomberg School of Public Health, in Molecular Microbiology and Immunology. She is an internationally recognized leader in studies of immune responses in immunocompetent and immunocompromised patient populations to viral infections and vaccines against them, including SARS-Co-V-2 (the virus that causes COVID-19), HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Dr. Cox earned her Ph.D. in chemistry from the University of Virginia, where she characterized peptides that drive T cell responses. She then earned her M.D. and completed internal medicine residency and infectious disease fellowship training at Johns Hopkins. She leads the largest prospective cohort study of acute HCV infection, designed to enable detailed molecular analysis of HCV transmission, host immune responses, and virus sequence evolution. She co-led the first prophylactic HCV vaccine trial in individuals at risk of HCV infection. She leads a multidisciplinary international team investigating HCV-specific immune responses to improve vaccine development against HCV, is the lead immunologist on a clinical trial of HBV vaccines in people living with HIV, and co-leads a large team investigating immune responses to COVID-19 infection and vaccines. In addition to her research on viral infections and vaccines, Dr. Cox is actively involved in clinical care of patients with HCV, HIV, and HBV infections. Dr. Cox serves as the director of the Medical Scientist Training Program. A teacher, advisor, and mentor of physician-scientists and scientists, Dr. Cox mentors Ph.D. students in the Johns Hopkins Cellular and Molecular Medicine, Molecular Microbiology and Immunology, and the Immunology graduate training programs. Dr. Cox is highly rated in 2 conditions, according to our data. Her top areas of expertise are Hepatitis C, Hepatitis, COVID-19, and HIV/AIDS.

Dr. Sara Keller graduated from the Duke University School of Medicine in 2007. She completed her Master of Public Health in epidemiology in 2006 at the University of North Carolina at Chapel Hill. She then completed a residency in Internal Medicine in the Osler Medical Residency Training Program at the Johns Hopkins Hospital in 2010, a fellowship in Infectious Diseases at the University of Pennsylvania in 2012, and a fellowship in the University of Pennsylvania Centers for Healthcare Improvement and Patient Safety in 2013. She also completed a Master of Science in Health Policy at the University of Pennsylvania in 2013. She is an Assistant Professor in Infectious Diseases where she primarily sees patients at Johns Hopkins Green Spring Station and also attends on the inpatient infectious disease consult service at the Johns Hopkins Hospital. She serves as the Medical Director of the Johns Hopkins Hospital Outpatient Parenteral Antimicrobial Therapy (OPAT) Service. Dr. Keller is highly rated in 2 conditions, according to our data. Her top areas of expertise are Asymptomatic Bacteriuria, Sepsis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Larry Chang is an Infectious Disease provider in Baltimore, Maryland. Dr. Chang is highly rated in 2 conditions, according to our data. His top areas of expertise are HIV/AIDS, Sepsis, Myelitis, and AIDS Dementia Complex. Dr. Chang is currently accepting new patients.

Dr. Michael T. Melia is an Associate Professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include general infectious diseases, HIV and Lyme disease. He serves as the Director of the Infectious Diseases Fellowship Program. After receiving his medical degree from the Georgetown University School of Medicine, Dr. Melia completed his internal medicine residency, infectious diseases fellowship, and chief medical residency at the Beth Israel Deaconess Medical Center. He joined the Johns Hopkins faculty in 2008. Dr. Melia's academic and research interests center around medical education and coaching in medicine. He is the current Chair of the IDSA Medical Education Community of Practice and is a past Chair of the IDSA Training Program Directors' Committee. In 2015, Dr. Melia was recognized with the Outstanding Achievement in Teaching Award from the Institute for Excellence in Education at the Johns Hopkins University School of Medicine. Dr. Melia is highly rated in 1 condition, according to our data. His top areas of expertise are Lyme Disease, Hepatitis C, Allergic Bronchopulmonary Aspergillosis, and HIV/AIDS.

Robert Redfield is an Infectious Disease provider in Timonium, Maryland. His top area of expertise is Long Haul COVID. Dr. Redfield is currently accepting new patients.

Brandon Eilertson is an Infectious Disease provider in Timonium, Maryland. His top areas of expertise are Cryptococcosis, Osteomyelitis, HIV/AIDS, and Myelitis. Dr. Eilertson is currently accepting new patients.

Shmuel Shoham, M.D. is Professor of Medicine at Johns Hopkins University School of Medicine. Dr. Shoham has over 20 years of experience in management of patients with invasive infections, and is the author or co-author of over 100 original articles, book chapters and topic reviews. He is a nationally recognized expert in infectious diseases of immunocompromised patients and his research explores diagnosis, prevention and treatment of infections in such patients. Dr. Shoham serves as a reviewer and expert consultant to multiple journals, professional societies, hospitals and government agencies in the US and numerous countries abroad. He is a member of professional guideline committees for the American Society of Transplantation (AST), the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and Infectious Diseases Mycoses Study Group (EORTC/MSG) and the National Comprehensive Cancer Network (NCCN). Dr. Shoham is the recipient of numerous awards including the American College of Physicians' (Washington, DC Chapter) laureate award, their highest honor. Dr. Shoham received his medical degree from Thomas Jefferson University (Philadelphia, PA) and medical residency and infectious diseases fellowship training at Boston University School of Medicine (Boston, MA). His top areas of expertise are Meningitis, Cryptococcosis, Cytomegalovirus Infection, and Cytomegalic Inclusion Disease.